Nabriva Therapeutics Plc (NBRV) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NBRV Annual Balance Sheets →
A period-by-period view of the balance sheet from Nabriva Therapeutics Plc to Jun 30 2022 helps clarify how Jun 30 2023's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2023)
(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Assets
Cash & cash equivalent2.18
Cash & Short-term Investments2.00
Accounts receivable4.44
Other Receivables0.00
Inventories0.00
Other Current Assets0.07
Prepaid Expense, Current AS3.26
Total Current Assets9.95
Equipment/Property/Plant Net0.25
Intangible Assets0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.38
Restricted Cash0.07
Total Assets10.58
Liabilities
Accounts Payable, Current AC14.03
Accrued Liabilities, Current AC11.98
Long-term Debt, Current Maturities LO0.20
Total Current Liabilities26.20
Long-term debt0.34
Total Long-term Debt0.34
Financial Instruments, Insurance, Noncurrent2.70
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.35
Total Liabilities26.90
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock657.24
Retained Earnings / Accumulated Deficit-673.62
Accumulated Other Comprehensive Income0.03
Other Equity0.03
Common Stockholder's Equity-16.32
Total Stockholder's Equity-16.32
Liabilities & Stockholder's Equity10.58
4 historic quarters locked

Sign in to unlock the full Nabriva Therapeutics Plc balance sheet history.

About Nabriva Therapeutics Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-23-016524

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.